top of page

ACG

h.o.l.M.E.S.

Automated Clinical Guidelines

sulfonylureas.jpg
Sulfonylureas

Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas. Originally available in 1984, it is marketed by Pfizer under the brand name Glucotrol in the USA, where Pfizer sells Glucotrol in doses of 5 and 10 milligrams and Glucotrol XL (an extended release form of glipizide) in doses of 2.5, 5, and 10 milligrams... Wikipedia

 

Manufacturer's Website: Not Available                                                                                                                                         Average retail cost: $34/month

glucotrolxl.jpg
Glucotrol XL (glipizide)
* Prices reflect U.S. average retail price

Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas. Originally available in 1984, it is marketed by Pfizer under the brand name Glucotrol in the USA, where Pfizer sells Glucotrol in doses of 5 and 10 milligrams and Glucotrol XL (an extended release form of glipizide) in doses of 2.5, 5, and 10 milligrams... Wikipedia

 

Manufacturer's Website: Not Available                                                                                                                                               Average retail cost: $323/month

glucotrol.jpg
Glucotrol (glipizide)

Glibenclamide, also known as glyburide, is an antidiabetic drug in a class of medications known as sulfonylureas, closely related to sulfonamide antibiotics. It was developed in 1966 in a cooperative study between Boehringer Mannheim (now part of Roche) and Hoechst (now part of Sanofi-Aventis)... Wikipedia

 

Manufacturer's Website: Not Available                                                                                                                                               Average retail cost: $110/month

glynase.png
Glynase (glyburide)

Glimepiride (original trade name Amaryl) is an orally available medium-to-long-acting sulfonylurea antidiabetic drug. It is sometimes classified as either the first third-generation sulfonylurea, or as second-generation... Wikipedia

 

Manufacturer's Website: Not Available                                                                                                                                                  Average retail cost: $115/month

amaryl_logo.jpg
Amaryl (glimepiride)
bottom of page